Seegene Middle East participated in OBS-GYNE 2017, the largest conference in the Middle East for obstetricians and gynecologists, which was held from April 19 to 21 at the Dubai International Conference & Exhibition Center. At this event, the company introduced detection of the products related to women’s health that conduct molecular diagnoses for sexually transmitted infections (STI) and human papillomavirus (HPV).

As the largest academic conference of its kind in the Middle East, OBS-GYNE brings together obstetricians and gynecologists from all over the region to exchange information on the latest treatment methods and medical technologies in their respective fields. Conference participants also share with one another professional knowledge on a diverse range of issues related to women’s health, including the health of pregnant women, prenatal health, reproductive organ diseases, and gynecological diseases.

Having attended this conference since 2015, Seegene Middle East participant in this event helps to secure a client base of state hospitals and test centers in the UAE.

Seegene Middle East’s Executive Director Mr. James (Jeehoon) Park commented, “In the past, the Middle East lagged behind other regions of the world in terms of the general perception of women’s health management due to its religious and social background. Recently, however, due to the expansion of women’s rights and diverse campaigns in the region, existing perceptions are undergoing significant changes. With the increased demand for high-quality medical services, particularly among young female consumers, the medical market that addresses these needs is growing rapidly. With its Anyplex™ II HPV HR Detection and Allplex™ STI/BV Panel Assays which enables selective test based on patients symptoms, Seegene will not only be seeking to expand its foothold in the molecular diagnosis market but also dedicate even more resources to securing new clients.”